Acyclovir forte - description of the drug, instructions for use, reviews. Medicinal guide geotar Use by pregnant and lactating mothers

Compound

One tablet contains:

active substance: acyclovir - 400 mg

Excipients: potato starch, lactose (milk sugar), povidone, sugar (sucrose), sodium lauryl sulfate, magnesium stearate.

Description

Tablets are white, biconvex, oblong in shape with rounded ends, scored on one side.

Pharmacotherapeutic group

Antiviral drug

Pharmacological properties

An antiviral drug, a synthetic analog of an acyclic purine nucleoside with a highly selective effect on herpes viruses. Inside the virus-infected cells, under the action of viral thymidine kinase, a series of successive reactions of acyclovir transformation into acyclovir mono-, di- and triphosphate takes place. Acyclovir a triphosphate is integrated into the viral DNA chain and blocks its synthesis through competitive inhibition of the viral DNA polymerase.

In vitro, acyclovir is effective against the herpes simplex virus - Herpes simplex types I and II, against the Varicella zoster virus; higher concentrations are required to inhibit the Epstein-Barr virus.

Pharmacokinetics

When taken orally, bioavailability is 15-30%. Acyclovir penetrates well into all organs and tissues of the body, including the brain and skin. Plasma protein binding is 9-33% and does not depend on its plasma concentration. The concentration in the cerebrospinal fluid is about 50% of its plasma concentration. Acyclovir crosses the placental barrier and accumulates in breast milk. The maximum concentration after oral administration of 200 mg 5 times a day is 0.7 μg / ml, the time to reach the maximum concentration is 1.5-2 hours.

It is metabolized in the liver with the formation of a pharmacologically inactive compound 9-carboxymethoxymethylguanine. The elimination half-life in adults with normal renal function is 2-3 hours. In patients with severe renal insufficiency, the half-life is 20 hours, with hemodialysis - 5.7 hours (in this case, the plasma concentration of acyclovir decreases to 60% of the initial value). About 84% is excreted by the kidneys unchanged and 14% - in the form of a metabolite. The renal clearance of acyclovir is 75-80% of the total plasma clearance. Less than 2% of acyclovir is excreted from the body through the intestines.

Indications for use

Treatment of infections of the skin and mucous membranes caused by viruses Herpes simplex type I and II, both primary and secondary, including genital herpes.

Prevention of exacerbations of recurrent infections caused by viruses Herpes simplex type I and II in patients with normal immune status.

Prevention of primary and recurrent infections caused by viruses Herpes simplex type I and II in patients with immunodeficiency.

· As part of the complex therapy of patients with severe immunodeficiency: with HIV infection (AIDS stage, early clinical manifestations and a detailed clinical picture) and in patients who underwent bone marrow transplantation.

Treatment of primary and recurrent infections caused by the virus Varicella zoster(chicken pox, as well as shingles - herpes zoster).

Contraindications

Hypersensitivity to acyclovir, ganciclovir or any excipient of the drug.

Taking the drug is contraindicated during lactation.

Children's age up to 3 years (for this dosage form).

Galactose intolerance, lactase deficiency, glucose-galactose malabsorption.

Carefully

Pregnancy; the elderly and patients receiving large doses, especially against the background of dehydration; impaired renal function; neurological disorders or neurological reactions to the intake of cytotoxic drugs (including history).

Pregnancy and lactation

Acyclovir crosses the placental barrier and accumulates in breast milk.

Use during pregnancy is possible only if the intended benefit to the mother outweighs the potential risk to the fetus. If necessary, taking acyclovir during lactation requires interruption of breastfeeding.

Method of application and dosage

inside. The drug is taken during or immediately after a meal and washed down with a sufficient amount of water.

The dosage regimen is set individually depending on the severity of the disease.

In the treatment of infections of the skin and mucous membranes caused by Herpes simplex types I and II Adults

the drug is prescribed 200 mg 5 times a day for 5 days at 4-hour intervals during the day and at 8-hour intervals at night. In more severe cases of the disease, the course of treatment can be extended by a doctor's prescription up to 10 days. As part of complex therapy for severe immunodeficiency, including with an advanced clinical picture of HIV infection (including early clinical manifestations of HIV infection and the stage of AIDS), after bone marrow implantation, 400 mg is prescribed 5 times a day.

For the prevention of recurrence of infections caused by Herpessimplex type I and II viruses, patients with a normal immune status and with a relapse of the disease are prescribed 200 mg 4 times a day every 6 hours, the duration of the course is from 6 to 12 months.

For the prevention of infections caused by Herpes simplex type I and II viruses, adults with immunodeficiency, the drug is recommended to prescribe 200 mg 4 times a day every 6 hours, the maximum dose is up to 400 mg of acyclovir 5 times a day, depending on the severity of the infection.

for infection caused herpes simplex and prevention of this infection in immunocompromised patients, children over 3 years of age receive the same dose as adults.

Varicella zoster adults

the drug is prescribed 800 mg 5 times a day every 4 hours during the day and with an 8-hour interval at night. The duration of the course of treatment is 7-10 days.

for chicken pox, 20 mg / kg 4 times a day for 5 days (maximum single dose 800 mg), children from 3 years to 6 years: 400 mg 4 times a day, over 6 years: 800 mg 4 times a day within 5 days.

In the treatment of infections caused by herpes zoster, adults are prescribed 800 mg 4 times a day every 6 hours for 5 days.

In patients with impaired renal function

in the treatment and prevention of infections caused by herpes simplex, in patients with creatinine clearance less than 10 ml / min, the dosage of the drug should be reduced to 200 mg 2 times a day at 12-hour intervals.

In the treatment of infections caused by Varicella zoster, in patients with creatinine clearance less than 10 ml / min, it is recommended to reduce the dosage of the drug to 800 mg 2 times a day at 12-hour intervals; with creatinine clearance up to 25 ml / min, 800 mg is prescribed 3 times a day at 8-hour intervals.

Side effect

The drug is usually well tolerated.

From the gastrointestinal tract: in isolated cases - abdominal pain, nausea, vomiting, diarrhea.

In blood: a transient slight increase in the activity of liver enzymes, rarely - a slight increase in the levels of urea and creatinine, hyperbilirubinemia, leukopenia, erythropenia.

From the side of the central nervous system: rarely - headache; weakness; in some cases, tremor, dizziness, fatigue, exhaustion, drowsiness, insomnia, paresthesia, confusion, hallucinations, decreased concentration, agitation.

Allergic reactions: anaphylactic reactions, skin rash, itching, Lyell's syndrome, urticaria, erythema multiforme exudative, incl. Stevens-Johnson syndrome, fever.

Others: rarely - alopecia, peripheral edema, visual impairment, lymphadenopathy, myalgia, malaise.

Overdose

There have been no cases of overdose after oral administration of acyclovir.

Acyclovir forte: instructions for use and reviews

Acyclovir forte is an antiviral drug.

Release form and composition

Dosage form of release of Acyclovir forte - tablets: white, oblong biconvex shape with rounded ends, on one side of the risk (5, 10, 12, 15, 20 or 30 pieces in blisters, in a carton pack 1-3 packs).

Composition of 1 tablet:

  • active substance: acyclovir - 400 mg;
  • auxiliary components: sugar, sodium lauryl sulfate, potato starch, magnesium stearate, lactose, povidone.

Pharmacological properties

Pharmacodynamics

Acyclovir forte is one of the antiviral drugs, synthetic analogues of the acyclic purine nucleoside, which have a highly selective effect on herpes viruses. Under the action of viral thymidine kinase, successive reactions of transformation of acyclovir into mono-, di- and triphosphate of acyclovir take place inside virus-infected cells. Acyclovir triphosphate is integrated into the viral DNA chain, blocking its synthesis through competitive inhibition of the viral DNA polymerase.

Acyclovir effectively acts against the herpes simplex virus - Herpes simplex types I and II, against the Varicella zoster virus; Epstein-Barr virus inhibition requires higher concentrations.

Pharmacokinetics

The bioavailability of acyclovir when taken orally is approximately 15-30%. The substance penetrates well into all tissues/organs of the body, including the brain and skin. Plasma protein binding ranges from 9 to 33% (does not depend on plasma concentration).

The concentration of acyclovir in the cerebrospinal fluid is about 50% of its plasma concentration. The maximum concentration after oral administration of 200 mg 5 times a day is 0.000 7 mg / ml. The time required to reach maximum concentration is 90 to 120 minutes. The substance crosses the placental barrier and accumulates in breast milk.

As a result of metabolism in the liver, a pharmacologically inactive compound, 9-carboxymethoxymethylguanine, is formed. In adult patients with normal renal function, the elimination half-life is 2-3 hours. In severe renal failure, the half-life increases to 20 hours, with hemodialysis it is 5.7 hours (the plasma concentration of acyclovir decreases to 60% of the initial value).

Approximately 84% of the substance is excreted unchanged by the kidneys, in the form of a metabolite - 14%. Renal clearance of acyclovir is 75 to 80% of total plasma clearance. Less than 2% of the substance is excreted through the intestines.

Indications for use

  • primary and secondary infections of the skin / mucous membranes caused by Herpes simplex type I and II viruses, including genital herpes (therapy);
  • recurrent infections caused by Herpes simplex type I and II viruses with a normal immune status (prevention of exacerbations);
  • primary / recurrent infections caused by Herpes simplex type I and II viruses in immunocompromised patients (prophylaxis);
  • primary / recurrent infections caused by the Varicella zoster virus, including chicken pox, as well as herpes zoster - Herpes zoster (therapy);
  • HIV infection (AIDS stage, early clinical signs and a detailed clinical picture), conditions after bone marrow transplantation (as part of complex treatment).

Contraindications

Absolute:

  • galactose intolerance, impaired absorption of galactose and glucose, lactase deficiency;
  • lactation period;
  • age up to 3 years;
  • individual intolerance to any component of the drug, as well as ganciclovir.

Relative (Acyclovir forte is prescribed under medical supervision):

  • the use of the drug in large doses, especially against the background of dehydration;
  • neurological disorders / reactions to the use of cytotoxic drugs, including a aggravated anamnesis;
  • violations of renal function;
  • pregnancy;
  • elderly age.

Instructions for use Acyclovir forte: method and dosage

Acyclovir forte 400 mg tablets are taken orally with a sufficient amount of water, preferably during or immediately after a meal.

The scheme of application is determined individually based on the severity of the disease.

Herpes simplex type I and II infections

Adults Acyclovir forte is prescribed 5 times a day (with breaks of 4 hours during the day and 8 hours at night) at a dose of 200 mg for 5 days. An increase in the duration of the course up to 10 days is possible with a severe course of the disease. A single dose of 400 mg is used for complex treatment of patients with severe immunodeficiency, including those with an advanced clinical picture of HIV infection, after bone marrow implantation.

For the prevention of recurrence of infections caused by Herpes simplex viruses, in the absence of immune status disorders and in case of relapse of the disease, Acyclovir forte is prescribed 4 times a day (with breaks of 6 hours) at a dose of 200 mg for 6–12 months. Adults with immunodeficiency for the prevention of infections are recommended to use the same dose of the drug. Maximum - 5 times a day up to 400 mg (depending on the severity of the infection).

For children, Acyclovir forte is prescribed according to the scheme used in adult patients.

Varicella zoster infections

  • adults: 5 times a day (with breaks of 4 hours during the day and 8 hours at night) 800 mg in a course of 7-10 days;
  • children (chickenpox): 4 times a day, 20 mg / kg (maximum - 800 mg) for 5 days; children 3-6 years old - 400 mg 4 times a day; children from 6 years old - 4 times a day, 800 mg.

Adults in the treatment of infections caused by Herpes zoster are prescribed 800 mg every 6 hours for a course of 5 days.

Features of use in patients with impaired renal function

  • Herpes simplex: with CC (creatinine clearance) less than 10 ml / min, Acyclovir forte is prescribed in a single dose of 200 mg, the frequency of administration is 2 times a day (with interruptions of 12 hours);
  • Varicella zoster: with CC less than 10 ml / min, Acyclovir forte is prescribed in a single dose of 800 mg, the frequency of administration is 2 times a day (with interruptions of 12 hours); with a CC of 10–25 ml / min, the drug should be taken in the same single dose, the frequency of administration is 3 times a day (with interruptions of 8 hours).

Side effects

Aciclovir forte 400 mg tablets are generally well tolerated.

Possible adverse reactions (> 10% - very often; > 1% and< 10% – часто; >0.1% and< 1% – нечасто; >0.01% and< 0,1% – редко; < 0,01%, включая отдельные сообщения – очень редко):

  • blood: a transient slight increase in the activity of liver enzymes; rarely - a slight increase in creatinine and urea levels, hyperbilirubinemia, erythropenia, leukopenia;
  • digestive system: in isolated cases - pain in the abdomen, diarrhea, vomiting, nausea;
  • nervous system: rarely - headache, weakness; in some cases - agitation, hallucinations, tremor, drowsiness, dizziness, exhaustion, fatigue, insomnia, paresthesia, decreased concentration, confusion;
  • allergic reactions: fever, skin rash, anaphylactic reactions, Lyell's syndrome, itching, urticaria, erythema multiforme exudative;
  • other reactions: rarely - peripheral edema, malaise, alopecia, lymphadenopathy, visual impairment, myalgia.

Overdose

There are no data on cases of overdose.

special instructions

Acyclovir forte does not prevent sexual transmission of herpes, and therefore it is recommended to abstain from sexual intercourse during the period of its use, even in cases where there are no clinical manifestations.

During therapy, patients need to ensure the flow of fluid in sufficient quantities.

During the period of taking the drug, it is necessary to monitor kidney function (the level of plasma creatinine and blood urea).

Use during pregnancy and lactation

  • pregnancy: taking Acyclovir forte is possible after assessing the benefit / risk ratio;
  • lactation period: therapy is contraindicated.

Application in childhood

Patients under 3 years of age are not prescribed the drug.

For impaired renal function

According to the instructions, Acyclovir forte is used with caution in case of impaired renal function.

Use in the elderly

Acyclovir forte should be prescribed to elderly patients under medical supervision.

drug interaction

Possible interactions:

  • probenecid: an increase in the mean half-life and a decrease in the clearance of acyclovir;
  • nephrotoxic drugs: increased risk of impaired renal function;
  • immunostimulants: increased effect.

Analogues

Analogues of Acyclovir forte are Gerperax, Gervirax, Medovir, Virolex, Acigerpin, Vivorax, Zovirax, Acyclovir, Provirsan.

Terms and conditions of storage

Store in a place protected from light and moisture, at temperatures up to 25 °C. Keep away from children.

Shelf life - 2 years.

Dosage form:   tablets Ingredients:

One tablet contains:

active substance : acyclovir - 400 mg

Excipients: potato starch, lactose (sugarmilk), povidone, sugar (sucrose), sodium lauryl sulfate, magnesium stearate.

Description:

Tablets are white, biconvex, oblong in shape with rounded ends, scored on one side.

Pharmacotherapeutic group:Antiviral agent ATX:  

S.01.A.D Antivirals

Pharmacodynamics:

An antiviral drug, a synthetic analog of an acyclic purine nucleoside with a highly selective effect on herpes viruses. Inside the virus-infected cells, under the action of viral thymidine kinase, a series of successive reactions of acyclovir transformation into acyclovir mono-, di- and triphosphate takes place. Acyclovir triphosphate is integrated into the viral DNA chain and blocks its synthesis through competitive inhibition of viral DNA polymerase.

In vitro acyclovir is effective against the herpes simplex virus - herpes simplex type I and II, against the virus Varicella zoster; higher concentrations are required to inhibit the Epstein-Barr virus. In vitro aciclovir is therapeutically and prophylactically effective primarily in viral infections caused by Herpes simplex.

Pharmacokinetics:

When taken orally, bioavailability is 15-30%. penetrates well into all organs and tissues of the body, includingbrain and skin. Plasma protein binding is 9-33% and does not depend on its plasma concentration. The concentration in the cerebrospinal fluid is about 50% of its plasma concentration. crosses the placental barrier and accumulates in breast milk. The maximum concentration after oral administration of 200 mg 5 times a day is 0.7 μg / ml, the time to reach the maximum concentration is 1.5-2 hours.

It is metabolized in the liver with the formation of a pharmacologically inactive compound 9-carboxymethoxymethylguanine. The elimination half-life in adults with normal renal function is 2-3 hours. In patients with severe renal insufficiency, the half-life is 20 hours, with hemodialysis - 5.7 hours (in this case, the plasma concentration of acyclovir decreases to 60% of the initial value). About 84% is excreted by the kidneys unchanged and 14% - in the form of a metabolite. The renal clearance of acyclovir is 75-80% of the total plasma clearance. Less than 2% of acyclovir is excreted from the body through the intestines.

Indications:

- Treatment of infections of the skin and mucous membranes caused by virusesHerpes simplex type I and II,both primary and secondary, including genital herpes.

- Prevention of exacerbations of recurrent infections caused by virusesHerpes simplex type I and II,patients with normal immune status.

- Prevention of primary and recurrent infections caused by virusesHerpes simplex typelull atpatients with immunodeficiency.

- As part of the complex therapy of patients with severeimmunodeficiency: with HIV infection (AIDS stage, earlyclinical manifestations and a detailed clinical picture) and in patients undergoing bone marrow transplantation.

- Treatment of primary and recurrent viral infectionsVaricella zoster(chicken pox, as well as shingles -Herpes zoster).

Contraindications:

Hypersensitivity to acyclovir, ganciclovir or any excipient of the drug.

Taking the drug is contraindicated during lactation.

Children's age up to 3 years (for this dosage form). Galactose intolerance, lactase deficiency, glucose-galactose malabsorption.

Carefully:

Pregnancy; the elderly and patients receiving large doses, especially against the background of dehydration; impaired renal function;neurological disorders or neurological reactions to the intake of cytotoxic drugs (including history).

Pregnancy and lactation:

Acyclovir crosses the placental barrier and accumulates in breast milk.

Use during pregnancy is possible only if the intended benefit to the mother outweighs the potential risk to the fetus. If necessary, taking acyclovir during lactation requires interruption of breastfeeding.

Dosage and administration:

inside. The drug is taken during or immediately after a meal and washed down with a sufficient amount of water.

The dosage regimen is set individually depending on the severity of the disease.

In the treatment of infections of the skin and mucous membranes caused by herpes simplex type I and II:

Adults:the drug is prescribed 200 mg 5 times a day for 5 days at 4-hour intervals during the day and at 8-hour intervals at night. In more severe cases of the disease, the course of treatment can be extended by a doctor's prescription up to 10 days. As part of complex therapy for severe immunodeficiency, including with an advanced clinical picture of HIV infection (including early clinical manifestations of HIV infection and the stage of AIDS), after bone marrow implantation, 400 mg is prescribed 5 times a day.

To prevent recurrence of infections caused by viruses Herpes simplex type I and II,patients with a normal immune status and with a relapse of the disease are prescribed 200 mg 4 times a day every 6 hours, the duration of the course is from 6 to 12 months.

To prevent infections caused by viruses Herpes simplex type I and II,adults with immunodeficiency, the drug is recommended to prescribe 200 mg 4 times a day every 6 hours, the maximum dose is up to 400 mg of acyclovir 5 times a day, depending on the severity of the infection.

Children: for infection causedHerpes simplexand prevention of this infection in immunocompromised patients, children over 3 years of age receive the same dose as adults.

Varicella zoster:

Adults:the drug is prescribed 800 mg 5 times a day every 4 hours during the day and with an 8-hour interval at night. The duration of the course of treatment is 7-10 days.

Children: for chicken pox, 20 mg / kg 4 times a day for 5 days (maximum single dose 800 mg), children from 3 years to 6 years: 400 mg 4 times a day, over 6 years: 800 mg 4 times a day within 5 days.

In the treatment of infections caused byHerpes zoster, adults are prescribed 800 mg 4 times a day every 6 hours for 5 days.

In patients with impaired renal function:

in the treatment and prevention of infections caused byHerpes simplex, in patients with creatinine clearance less than 10 ml / min, the dosage of the drug should be reduced to 200 mg 2 times a day at 12-hour intervals.

In the treatment of infections caused byVaricella zoster, in patients with creatinine clearance less than 10 ml / min, it is recommended to reduce the dosage of the drug to 800 mg 2 times a day at 12-hour intervals; with creatinine clearance up to 25 ml / min, 800 mg is prescribed 3 times a day at 8-hour intervals.

Side effects:

The drug is usually well tolerated.

From the gastrointestinal tract: in isolated cases - pain instomach, nausea, vomiting, diarrhea.

In blood:transient slight increase in the activity of liver enzymes, rarely - a slight increase in the levels of urea and creatinine, hyperbilirubinemia, leukopenia, erythropenia.

From the side of the central nervous system: rarely - headache; weakness; in some cases, tremor, dizziness, fatigue, exhaustion, drowsiness, insomnia, paresthesia, confusion, hallucinations, decreased concentration, agitation.

Allergic reactions: anaphylactic reactions, skin rash, itching, Lyell's syndrome, urticaria, erythema multiforme exudative, incl. Stevens-Johnson syndrome, fever.

Others:rarely - alopecia, peripheral edema, visual impairment, lymphadenopathy, myalgia, malaise.

Overdose:

There have been no cases of overdose after oral administration of acyclovir.

Interaction:

Simultaneous use with probenecid leads to an increase in the mean half-life and a decrease in the clearance of acyclovir.

When taken simultaneously with nephrotoxic drugs, the risk of impaired renal function increases.

Strengthening the effect is noted with the simultaneous appointment of immunostimulants.

Special instructions:

Use strictly according to the doctor's prescription to avoid complications in adults and children over 3 years old.

With caution appoint patients with impaired renal function, elderly patients due to an increase in the half-life of acyclovir.

When using the drug, it is necessary to ensure the flow of a sufficient amount of liquid.

When taking the drug, kidney function (blood urea and plasma creatinine) should be monitored.

Acyclovir does not prevent sexual transmission of herpes, therefore, during the treatment period, it is necessary to refrain from sexual intercourse, even in the absence of clinical manifestations.

Due to the presence of lactose, patients with rare hereditary diseases such as galactose intolerance, lactase deficiency, glucose-galactose malabsorption should not take the drug.

Release form / dosage:Tablets of 400 mg. Package:

5, 10, 12, 15, 20 or 30 tablets in a blister pack.

1, 2 or 3 blister packs, together with instructions for use, are placed in a cardboard pack.

Storage conditions:

List B.

In a dry, dark place at a temperature not exceeding 25 ° C. Keep out of the reach of children.

Best before date:

2 years.

Do not use after the expiration date.

Conditions for dispensing from pharmacies: On prescription Registration number: LSR-007061/09 Date of registration: 07.09.2009 Expiration date: Perpetual

inside. The drug is taken during or immediately after a meal and washed down with a sufficient amount of water. The dosage regimen is set by the doctor and individually, depending on the severity of the disease. In the treatment of infections of the skin and mucous membranes caused by Herpes simplex type I and II: Adults: the drug is prescribed 200 mg 5 times a day for 5 days at 4-hour intervals during the day and at 8-hour intervals at night. In more severe cases of the disease, the course of treatment can be extended by a doctor's prescription up to 10 days. As part of complex therapy for severe immunodeficiency, including with an advanced clinical picture of HIV infection (including early clinical manifestations of HIV infection and the stage of AIDS), after bone marrow implantation, 400 mg is prescribed 5 times a day. For the prevention of recurrence of infections caused by Herpes simplex type I and II viruses, patients with normal immune status and with a relapse of the disease are prescribed 200 mg 4 times a day every 6 hours, the duration of the course is from 6 to 12 months. For the prevention of infections caused by Herpes simplex type I and II viruses, adults with immunodeficiency, the drug is recommended to prescribe 200 mg 4 times a day every 6 hours, the maximum dose is up to 400 mg of acyclovir 5 times a day, depending on the severity of the infection. Children: For Herpes simplex infection and prevention of this infection in immunocompromised patients, children over 3 years of age receive the same dose as adults. In the treatment of infections caused by Varicella zoster: Adults: the drug is prescribed 800 mg 5 times a day every 4 hours during the day and at 8-hour intervals at night. The duration of the course of treatment is 7-10 days. Children: for chickenpox, 20 mg / kg are prescribed 4 times a day for 5 days (maximum single dose 800 mg), children from 3 years to 6 years: 400 mg 4 times a day, over 6 years: 800 mg 4 times per day for 5 days. In the treatment of infections caused by Herpes zoster, adults are prescribed 800 mg 4 times a day every 6 hours for 5 days. In patients with impaired renal function: In the treatment and prevention of infections caused by Herpes simplex, in patients with creatinine clearance less than 10 ml / min, the dosage of the drug should be reduced to 200 mg 2 times a day at 12-hour intervals. In the treatment of infections caused by Varicella zoster, in patients with creatinine clearance less than 10 ml / min, it is recommended to reduce the dosage of the drug to 800 mg 2 times a day at 12-hour intervals; with creatinine clearance up to 25 ml / min, 800 mg is prescribed 3 times a day at 8-hour intervals.

Compound

1 tablet contains:
active substance: acyclovir 400 mg;
Excipients: potato starch, lactose (milk sugar), povidone, sugar (sucrose), sodium lauryl sulfate, magnesium stearate.

Indications for use Acyclovir Forte

Treatment and prevention of infections caused by Herpes simplex types 1 and 2 and Varicella zoster viruses:

  • simple herpes of the skin and mucous membranes (primary and recurrent);
  • genital herpes (primary and recurrent);
  • shingles (shingles);
  • chickenpox (in the first 24 hours after the onset of a typical rash);
  • in patients with severe immunodeficiency (including after transplantation, when taking immunosuppressive drugs, in HIV-infected patients, during chemotherapy).

Contraindications to the use of Acyclovir Forte

  • hypersensitivity to acyclovir, ganciclovir or components of the drug;
  • lactation period (breastfeeding).
  • children's age up to 3 years.

FROM caution the drug should be prescribed for dehydration, renal failure, neurological disorders, incl. in history.

The dosage regimen is set individually depending on the severity of the disease.
In the treatment of infections of the skin and mucous membranes caused by the Herpes simplex virus types 1 and 2, Acyclovir is prescribed 200 mg 5 times a day for 5 days at intervals of 4 hours during the day and at intervals of 8 hours at night. In more severe cases of the disease, an increase in the course of treatment is possible.
As part of complex therapy for severe immunodeficiency, including with an advanced clinical picture of HIV infection (including early clinical manifestations of HIV infection and the stage of AIDS), after bone marrow implantation appoint 400 mg 5 times a day.
For the prevention of recurrence of infections caused by the Herpes simplex type 1 and 2 virus in patients with a normal immune status and in case of relapse of the disease appoint 200 mg 4 times a day every 6 hours.
For the prevention of infections caused by the Herpes simplex virus types 1 and 2,adults and children over 2 years old with immunodeficiency, the drug is prescribed 200 mg 4 times a day every 6 hours, the maximum dose is 400 mg 5 times a day.
, adults appoint 800 mg 5 times a day at intervals of 4 hours during the day and at intervals of 8 hours at night. The duration of the course of treatment is 7-10 days. Children over 2 years old appoint 20 mg/kg of body weight 4 times a day for 5 days, children weighing over 40 kg the drug is prescribed in the same dosage as for adults.

In the treatment of herpes zoster (Herpes zoster), adults appoint 800 mg 4 times / day every 6 hours for 5 days. Children over 6 years old - 800 mg 4 times a day; 2-6 years old - 400 mg 4 times a day; under 2 years old - 200 mg 4 times a day. More precisely, the dose can be determined at the rate of 20 mg / kg, but not more than 800 mg 4 times a day. The course of treatment is 5 days.
In patients with severe renal impairment (CK) with treatment and prevention of infections caused by the Herpes simplex virus, the drug is prescribed 200 mg 2 times a day at intervals of 12 hours.
In the treatment of infections caused by the Varicella zoster virus, for patients with CC, the drug is prescribed 800 mg 2 times a day at intervals of 12 hours; at CC from 10 to 25 ml / min- 800 mg 3 times a day at intervals of 8 hours.
The drug should be taken during or immediately after a meal and drink plenty of water.

pharmachologic effect

Acyclovir is an antiviral (antiherpetic) agent for external use - a synthetic analogue of the thymidine nucleoside, which is a natural component of DNA.
In infected cells containing viral thymidine kinase, phosphorylation and conversion to acyclovir monophosphate occurs. Under the influence of acyclovir guanylate cyclase, monophosphate is converted to diphosphate and, under the action of several cellular enzymes, to triphosphate. The high selectivity of action and low toxicity to humans are due to the lack of the necessary enzyme for the formation of acyclovir triphosphate in intact cells of the macroorganism.

Acyclovir triphosphate inhibits the synthesis (replication) of viral DNA by three mechanisms: 1) competitively replaces deoxyguanosine triphosphate in DNA synthesis; 2) "embeds" in the synthesized DNA chain and stops its elongation; 3) inhibits the enzyme DNA polymerase of viruses. As a result, the reproduction of the virus in the human body is disrupted.
The specificity and very high selectivity of action are also due to its predominant accumulation in cells affected by the herpes virus.
Highly active against Herpes simplex viruses 1 and 2 types; the virus that causes varicella and shingles (Varicella zoster); Epstein-Barr virus (types of viruses are listed in ascending order of the value of the minimum inhibitory concentration of acyclovir).

Moderately active against cytomegalovirus.
With herpes, it prevents the formation of new elements of the rash, reduces the likelihood of skin dissemination and visceral complications, accelerates the formation of crusts, and reduces pain in the acute phase of herpes zoster. It has an immunostimulating effect.

Side effects of Acyclovir Forte

From the digestive system: in isolated cases - abdominal pain, nausea, vomiting, diarrhea; rarely - a transient increase in the activity of liver enzymes, hyperbilirubinemia.
From the hematopoietic system: rarely - leukopenia, erythropenia.
From the side of the central nervous system: rarely - headache, weakness; in some cases - tremor, dizziness, fatigue, drowsiness, hallucinations.
Allergic reactions: skin rash; rarely - allergic dermatitis (when using the ointment).
Others: rarely - alopecia, fever, increased levels of urea and creatinine.

special instructions

With caution, Acyclovir should be prescribed to patients with impaired renal function, elderly patients due to an increase in the half-life of acyclovir.
When using the drug, it is necessary to ensure the flow of a sufficient amount of liquid.
The ointment is not recommended to be applied to the mucous membranes of the mouth, eyes, genitals, because. development of the expressed local inflammation is possible.
The effectiveness of treatment when applying the ointment will be the higher, the earlier it is started.
In patients with immunodeficiency with multiple repeated courses of treatment, the formation of viral resistance to acyclovir sometimes occurs.
When taking the drug, kidney function (blood urea and plasma creatinine) should be monitored.

drug interaction

With simultaneous use with probenecid, the mean half-life increases and the clearance of acyclovir decreases.
When taken simultaneously with nephrotoxic drugs, the risk of developing renal dysfunction increases.

Storage conditions

Store in a dry, dark place, out of the reach of children, at a temperature not exceeding 25°C.

Similar posts